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Abstract
Medical imaging market consists of several billion tests per year worldwide. Out of these, at least
one third are cardiovascular procedures. Keeping in mind that each test represents a cost, often a
risk, and a diagnostic hypothesis, we can agree that every unnecessary and unjustifiable test is one
test too many. Small individual costs, risks, and wastes multiplied by billions of examinations per
year represent an important population, society and environmental burden. Unfortunately, the
appropriateness of cardiac imaging is extra-ordinarily low and there is little awareness in patients
and physicians of differential costs, radiological doses, and long term risks of different imaging
modalities. For a resting cardiac imaging test, being the average cost (not charges) of an
echocardiogram equal to 1 (as a cost comparator), the cost of a CT is 3.1x, of a SPECT 3.27x, of
a Cardiovascular Magnetic Resonance imaging 5.51x, of a PET 14.03x, and of a right and left heart
catheterization 19.96x. For stress cardiac imaging, compared with the treadmill exercise test equal
to 1 (as a cost comparator), the cost of stress echocardiography is 2.1x and of a stress SPECT
scintigraphy is 5.7x. Biohazards and downstream long-term costs linked to radiation-induced
oncogenesis should also be considered. The radiation exposure is absent in echo and magnetic
resonance, and corresponds to 500 chest x rays for a sestamibi cardiac stress scan and to 1150
chest x rays for a thallium scan. The corresponding extra-risk in a lifetime of fatal cancer is 1 in
2000 exposed patients for a sestamibi stress and 1 in 1000 for a thallium scan. Increased awareness
of economic, biologic, and environmental costs of cardiac imaging will hopefully lead to greater
appropriateness, wisdom and prudence from both the prescriber and the practitioner. In this way,
the sustainability of cardiac imaging will eventually improve.
The unbearable lightness of being [a cardiac 
imaging specialist]
A Renaissance of cardiac imaging occurred in the 1980s
[1]. New technologies allowed the non-invasive descrip-
tion of cardiac function, perfusion, and metabolism in a
polychrome, three-dimensional, overwhelming fashion.
Almost unlimited resources were devoted to patient care
in the economic framework of the affluent society. At the
beginning of the 1990s, The Renaissance made its transi-
tion into the splendid decadence of the Baroque. The
increasing technological burden in clinical cardiology par-
adoxically did not bring a parallel increase in the quality
of care but rather an increase in cost. The economic cli-
mate had changed; the illusion of unlimited economic
resources had come to an end [2]. Keeping in mind that
each test represents a cost, often a risk, and always a diag-
nostic hypothesis, we can agree that every unnecessary
and unjustifiable test is one test too many. Small individ-
ual costs, risks, and wastes multiplied by billions of exam-
inations per year represent an important population [3],
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society [4] and environmental [5] burden. Unfortunately,
the appropriateness of cardiac imaging is usually extra-
ordinarily low and there is little awareness among
patients and physicians of the elementary physical basis,
differential costs, radiological doses, and long term risks
of different imaging modalities [6]. It is also well known
that – in the words of Bernard Lown – "technology in med-
icine is frequently untested scientifically, often applied without
data relating to cost benefit, and driven by market forces rather
than by patient needs." Bernard Lown, 2004 [7].
The cost of cardiac imaging
"Ten years ago, medical imaging wasn't even in the radar
screen for most health insurers. In 2004, it' s one of the highest
cost items in a health plan's medical budget, and also one of the
fastest growing". (Atlantic info service newsletter, 2004)
[8]. As an example, in U.S. during the year 2002, 7.8 mil-
lion cardiac perfusion scans were performed, with a
growth of 40% in the last 3 years [9]. Still in U.S., about
10 million CT scans were done in 1993, and about 60 mil-
lions in 2001 [10]. Booz Allen Hamilton projects that
spending on diagnostic imaging could grow 28 % by
2005, with utilization growing by 9% per year. No doubt
that any assessment of costs of medical imaging should
also include the often unquestionable downstream bene-
fits, leading to a reduction of overall costs due to more dis-
abling disease prevented. For instance, ultrasound
screening for abdominal aneurysms can reduce the risk of
death by more than 50 % in men aged 65–74. When pro-
jected to 10 years, that screening costs 13.000 dollars per
life year gained – a highly favourable result in terms of
cost-effectiveness [11]. However, it is beyond question
that the explosion in imaging costs is also driven by a
number of factors which not always improve the cost-
effectiveness. High patient demand for the newest diag-
nostic tests, physicians eager to use the most effective tech-
nologies, and possibly even some providers who may
boost utilization to help pay off investments in high-tech
equipment. All too often physicians may not have ade-
quate controls on the number of high cost imaging tests
they are ordering. For a resting cardiac imaging test, being
the average cost (not charges) of an echocardiogram equal
to 1 (as a cost comparator), the cost of a CT is 3.1x, of a
SPECT 3.27x, of a Cardiovascular Magnetic Resonance
imaging 5.51x, of a PET 14.03x, and of a right and left
heart catheterization 19.96x (Fig 1) [12]. For stress cardiac
imaging, compared with the treadmill exercise test equal
to 1 [as a cost comparator], the cost of stress echocardiog-
raphy is 2.1x and of a stress SPECT scintigraphy is 5.7x
[13]. Obviously, the evaluation of costs of medical imag-
ing should also imply the entire clinical context (pre-test
likelihood of disease, basic risk profile, target of stress test-
ing, socio-economic characteristics of the health care sys-
tem, etc.) to be taken into account. Some measures of
precision and/or dispersion of each modality as compared
to echocardiography may provide a more comprehensive
information in the specific health care milieu where these
tests are actually performed.
The individual and social risks of imaging
Current protection standard and practices are based on
the premise that any ionising radiation dose, no matter
how small, can result in detrimental health effects [14].
These include long-term development of cancer and
genetic damage [15]. For the purposes of radiation protec-
tion, the dose-response curve for radiation-induced cancer
is assumed to be linear at low doses, with no minimum
threshold [16]: (Fig. 2). The dose of 50 chest X rays (for
example, a lung scintigraphy) corresponds to an extra-risk
of cancer of about 1 in 20,000 exposed patients. The dose
of 500 chest x rays (such as technetium sestamibi scan)
corresponds to an extra-risk of about 1 in 2000 exposed
patients. The dose of 1 000 chest x rays (associated with a
Thallium scan) corresponds to an extra risk of cancer of
about 1 in 1 000 exposed patients [17]. The radiation dose
and risk associated with some common imaging examina-
tions are expressed in Table 1 as equivalent dose of natural
yearly background radiation, extra-risk of fatal cancer in
the lifetime and lost life expectancy per exam [18]. Pre-
sented data refer to the best available estimates from the
radiological Commission of Radiation Protection and
conform to their suggested standards for communicating
risk to patients. These estimations are a benchmark for the
physicians and are incorporated in the European Com-
mission guidelines for medical imaging. These small indi-
vidual risks multiplied by billion examinations become
significant population risk.
Use of radiation for medical examinations and test is the
largest manmade source of radiation exposure. The medi-
cal sources of radiation were about one fifth of the natural
radiation in 1987 [18], close to one-half in 1993 [19], and
almost 100% of natural radiation in 1997 [20], and the
use of procedures with a high load of radiation continues
to grow steadily [21].
This impressive amount of ionizing friendly fire translates
into a significant population risk. Lifetime risk of develop-
ing cancer attributable to diagnostic X-rays is 0.6–3.2% in
developed countries [22]. The numbers are striking, but
underestimate the biological population burden of medi-
cal radiation for three reasons. First, they refer to the radi-
ological volume of 10 years ago – substantially lower than
the current radiological volume. Second, they do not con-
sider the practice of nuclear medicine, which adds a fur-
ther 10 % to the global radiation burden. Third, in
addition to the risk of cancer, one should consider the
burden of teratogenesis. The risk of radiation – induced
damage passed onto the offspring is estimated to repre-
sent a fifth of the risk of fatal cancer [23].Cardiovascular Ultrasound 2005, 3:13 http://www.cardiovascularultrasound.com/content/3/1/13
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Unawareness in imaging
Several recent studies clearly prove that not only general
practitioners but also cardiologists, orthopaedics and
even radiologists and nuclear physicians usually ignore
the dose and the risk of what they do: and the more they
do, the more they tend to ignore [24-28]. Radiologists
working in an academic US environment frequently
underestimate of 100 to 500 times the dose of a common
CT and 97 % of UK doctors underestimate of sixteen times
the dose of a common CT chest scan. In 1 case out of 10,
doctors believe that magnetic resonance employs ionising
radiations, and 1 case out of 20 that ultrasound employs
ionising radiation [25,27]. The majority of doctors, and
even of radiologists, is not aware of the oncogenic risk of
common, high dose radiological examinations [26,28].
The vast majority of cardiologists underestimates of 200
up to 1000 times the dose of a stress cardiac perfusion
scintigraphy [28]: Figure 3. This unawareness generates
inappropriateness, which is an endemic and pervasive dis-
ease in the world of cardiac imaging. We need more pru-
dence, wisdom and responsibility in indicating and
performing (cardiac) imaging tests. Prudence and respon-
sibility should obviously be especially high for more
expensive tests, greater for those exposing the patient to
significant ionizing radiation [29], and greatest in special
subset particularly vulnerable to the damaging effects of
ionizing radiation, such as women in reproductive age
[30] and children [31-33].
The average costs of CMR and other common cardiac imaging procedures when compared 2 D echocardiography (modified  from Pennell, ref. 12) Figure 1
The average costs of CMR and other common cardiac imaging procedures when compared 2 D echocardiography (modified 
from Pennell, ref. 12).Cardiovascular Ultrasound 2005, 3:13 http://www.cardiovascularultrasound.com/content/3/1/13
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Presentation of cancer risk and radiation dose (in multiples of dose from a simple chest x rays) for some common radiological  and nuclear medicine examinations (Modified from Picano E, ref. 37) Figure 2
Presentation of cancer risk and radiation dose (in multiples of dose from a simple chest x rays) for some common radiological 
and nuclear medicine examinations (Modified from Picano E, ref. 37)
Table 1: Radiation doses and estimated cancer risk from common radiological examinations and isotope scans
Type of test Effective 
radiation dose 
(mSv)
Equivalent period of 
natural background 
radiation
Lifetime additional risk of 
cancer/examination
Lost life 
expectancy
Equivalent n. of 
chest x-rays
Chest radiograph 0.01 A few days Negligible risk 2 minutes 1
Skull radiograph 0.1 A few weeks Minimal risk 
(1 in 100,000 to 1 in1,000,000)
20 minutes 5
Lung isotope scan 1 A few months to a year Very low risk 
(1 in 10,000 to 1 in 100,000)
3 hrs 50
Cardiac gated study 10 A few years
(4 years)
Low risk
(1 in 2,000)
2 days 500
Thallium scan 20 (8 years) (1 in 1,000) 4 days 1000
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From benefit to risk-benefit
According to the International Commission of Radiologi-
cal Protection "Medical exposure is the only category in
which large reductions in average dose are possible, and it
is therefore highly desirable to reduce applications of
medical radiation which are of no benefit to the patients
and to minimise useless radiation in the course of medical
examinations" [34]
In other words it is desirable to adopt a radiation sparing
strategy not only for the physician and the patients but
also for the society and the environment. Nuclear medi-
cine and X-ray procedures are intended, as stated by the
United Nations Annex on Medical Exposures, "to provide
doctors with diagnostic information and in principle con-
ducted with the lowest practicable levels of patient dose to
meet clinical objectives" [5]. The clinical counterpart of
this concept is that it is not enough that a test is marginally
"better" than the other to justify its use: the extra-value
should be proportional to the extra-cost and to the extra-
risk. Both the physician and the patient should be well
aware of the different individual risks and social costs
posed by different diagnostic options. As recently stated
by guidelines on fluoroscopically guided invasive cardio-
vascular procedures, " the core principle governing the use
of ionizing radiation is ALARA (as low as reasonably
achievable). The ALARA principle recognizes that there is
no magnitude of radiation exposure that is known to be
completely safe. This principle confers a responsibility on
all physicians to minimize the radiation injury hazard to
What cardiologists know about dose of a test they prescribe and/ or perform daily Figure 3
What cardiologists know about dose of a test they prescribe and/ or perform daily. 2 out of 3 physicians underestimate of 100 
to 500 times the dose of a cardiac scintigraphy. The dose is equivalent to 500 chest x rays with technetium sestamibi, and to 
more than 1000 chest x rays with thallium scan (modified from Correia et al, ref 28)Cardiovascular Ultrasound 2005, 3:13 http://www.cardiovascularultrasound.com/content/3/1/13
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their patients, to their professional staff, and to them-
selves" [35]. If the information is comparable, every effort
should be done to orient the patient towards non-ioniz-
ing testing. If it is true that "local expertise and availability
should guide the selection of imaging techniques" [36], it
is also true that the doses and risks associated with the dif-
ferent diagnostic options should be clearly spelled out to
allow the patient and the prescriber to make an informed
decision. This policy is encouraged by common sense
[37], deontologic code [38], European Commission imag-
ing guidelines [14] and the European law [39]. It propels
to use a green technique whenever the information sup-
plied is grossly comparable to the red one [40].
The basic concept underlying this cardiac imaging para-
digm shift is obvious but is presently neglected. Medical
images of heartbreaking beauty when considering the
benefit, can be ambiguous when considering the cost-
benefit relationship, and unacceptable when considering
the risk-benefit. In this transition, we as physicians and
imaging specialists, are the critical link. "Health profession-
als involved in the processes of diagnosis and treatment are the
critical link. Training them properly and ensuring intensive
information exchange among them are, therefore, probably the
most cost-effective ways of achieving patient safety" [4]. (Inter-
national Action Plan for the radiological Protection of
patients).
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